ClinicalTrials.Veeva

Menu
C

Clintrial s.r.o. | Prague, Czech Republic

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

BI 1358894
Desvenlafaxine
Quetiapine
Lu AG09222
Methotrexate
Vortioxetine
Tavapadon
Povorcitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 7 total trials
Locations recently updated

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib

Atopic dermatitis is an ongoing condition that causes skin irritation, redness, and itchiness. Treatments are usually topical - applied to the skin (...

Enrolling
Moderate to Severe Atopic Dermatitis
Drug: Methotrexate
Drug: Placebo

The purpose of this study is to evaluate the safety and efficacy of long-term administration of flexible doses of tavapadon in participants with Park...

Invitation-only
Parkinson Disease
Drug: Tavapadon

Trial sponsors

Boehringer Ingelheim logo
Lundbeck logo
Cerevel Therapeutics logo
Incyte logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems